SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Spekulatius who wrote (40513)12/10/2010 10:31:07 AM
From: Jurgis Bekepuris  Respond to of 78748
 
Told ya that takeovers/buyouts are very unpredictable. :)

No position.



To: Spekulatius who wrote (40513)12/10/2010 5:38:44 PM
From: voodooist  Respond to of 78748
 
Spekulatius, I too messed up on BEC, buying at/near the lows and flipping out for a small profit (46.65) on my way to 90% cash. Next time I'll post my sells to help y'all. OTOH, I sold a bunch of THC today (probably prematurely, TAKE NOTE) at 6.51. And a former very small holding, ESL, just keeps on trucking.
I have never been so out of synch with the market as I am now. Cash, a truckload of BMY and PFE, and some penny stuff.



To: Spekulatius who wrote (40513)2/7/2011 10:29:02 AM
From: E_K_S  Respond to of 78748
 
Good call Spekulatius. I have been watching this one for a long time but never picked up a position. It looks like they got 35% more than when you first posted the article update on 12/10/2010.

RE: Beckman Coulter, Inc. Common St(NYSE: BEC )

Feb. 7, 2011, 8:58 a.m. EST
Danaher to buy Beckman Coulter for $6.8 billion
Investors bid shares of both companies higher
marketwatch.com

From the article:"...Danaher, a conglomerate that owns the Craftsman hands-tool brand as well as businesses in electronic testing, dental technologies and monitoring products, said Beckman Coulter’s portfolio would complement its existing life-sciences and diagnostics businesses...."

--------------------------------------------------------------------

I wonder if the remaining diagnostic companies will carry a premium given the level of interest in this offer?

Are there any others you follow? I have a small position in Covidien plc (COV) but they are not really in the diagnostic sector.

EKS